Nvni Group Gets Nasdaq Deficiency Notice Over Audit Committee Size

Ticker: NVNIW · Form: 6-K · Filed: Jan 12, 2024 · CIK: 1965143

Complexity: simple

Sentiment: bearish

Topics: corporate-governance, compliance, nasdaq-listing, board-changes

TL;DR

**Nvni Group got a Nasdaq warning for having too few audit committee members; they need to fix it or risk delisting.**

AI Summary

Nvni Group Limited received a deficiency notice from Nasdaq on January 12, 2024, because its Audit Committee now has only two members, falling short of Nasdaq's required three, following Randy Millian's resignation on December 29, 2023. This notice is not an immediate delisting threat but gives Nvni Group until December 30, 2024, or potentially June 26, 2024, to appoint a new director and regain compliance. Investors should care because failure to fix this could lead to delisting, making the stock harder to trade and potentially less valuable.

Why It Matters

This matters because if Nvni Group fails to appoint a third independent director to its Audit Committee within the cure period, its shares could be delisted from Nasdaq, which would significantly reduce liquidity and investor confidence.

Risk Assessment

Risk Level: medium — The company faces a compliance issue that, if not resolved, could lead to delisting, which is a significant risk for investors.

Analyst Insight

A smart investor would monitor Nvni Group's announcements closely for news of a new independent director appointment to the Audit Committee, as failure to resolve this by the December 30, 2024 deadline could lead to delisting and significant share price depreciation.

Key Players & Entities

Forward-Looking Statements

FAQ

What specific Nasdaq rule did Nvni Group Limited violate?

Nvni Group Limited violated Nasdaq's audit committee requirement as set forth in Listing Rule 5605, specifically regarding the number of members on the Audit Committee.

Who resigned from Nvni Group's board and audit committee, leading to this deficiency?

Randy Millian resigned from the board of directors and the audit committee of Nvni Group Limited, effective December 29, 2023.

How many members does Nvni Group's Audit Committee currently have, and how many are required by Nasdaq?

Nvni Group's Audit Committee is currently comprised of only two members, while Nasdaq Listing Rule 5605 requires three members.

What is the primary cure period deadline given by Nasdaq to Nvni Group Limited?

Nasdaq will provide Nvni Group Limited a cure period until the earlier of the Company's next annual shareholders' meeting or December 30, 2024, to regain compliance.

What is the consequence if Nvni Group Limited fails to regain compliance by the end of the cure period?

If compliance is not achieved by the expiration of the applicable cure period, Nvni Group Limited will receive written notification that its securities are subject to delisting.

Filing Stats: 391 words · 2 min read · ~1 pages · Grade level 15.8 · Accepted 2024-01-12 16:15:58

Filing Documents

From the Filing

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-41823 Nvni Group Limited P.O. Box 10008, Willow House, Cricket Square Grand Cayman, Cayman Islands KY1-1001 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Explanatory Note On January 12, 2024, Nvni Group Limited (the Company), received a deficiency notice (the Notice) from the Nasdaq Stock Market (Nasdaq) notifying the Company that, as a result of the resignation of Randy Millian from the board of directors of the Company (the Board) and the audit committee of the Board (the Audit Committee) effective December 29, 2023, the Company is no longer in compliance with Nasdaqs audit committee requirement as set forth in Listing Rule 5605, because the Audit Committee is now comprised of only two members instead of the required three members. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Companys ordinary shares on the Nasdaq Capital Market. The Notice states that, consistent with Listing Rule 5605(c)(4), Nasdaq will provide the Company a cure period in order to regain compliance as follows: (i) until the earlier of the Companys next annual shareholders meeting or December 30, 2024; or (ii) if the next annual shareholders meeting is held before June 26, 2024, then the Company must evidence compliance no later than June 26, 2024. If compliance is not achieved by the expiration of the applicable cure period, the Notice states that the Company will receive written notification that its securities are subject to delisting. At that time, the Company may appeal the delisting determination to a Hearings Panel. We expect to regain compliance with the Nasdaq Listing Rules prior to the expiration of the applicable cure period provided by Nasdaq. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. NVNI GROUP LIMITED Date: January 12, 2024 By: /s/ Pierre Schurmann Pierre Schurmann, Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing